Skip to main content
Explore URMC
menu

Jonathan W. Friedberg, M.D., M.M.Sc.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Administrative: (585) 275-4911

Office: (585) 275-5823

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Cancer

Biography

As Director of the Wilmot Cancer Institute, I seek to provide the highest level of compassionate care for patients, ensuring access to novel treatments and clinical trials whenever possible. My background brings the entire continuum of lymphoma experience to patients, from diagnosis through all treatments including autologous stem cell transplantation, CAR-T cell interventions, novel agents, and survivorship.

We have built an incredibly strong team in Rochester to care for patients with lymphoma that is absolutely first rate and internationally recognized. We have expertise in hematopathology, radiation oncology, dermatology and neurology, in addition to hematology and medical oncology. Driving this team toward excellence – and seeing our success – is highly rewarding.

Our understanding of blood cancers in general, and specifically lymphoma, has enabled us to cure a subset of patients – and that attracted me to this specialty. Happily, this fraction of cured patients has substantially increased during my almost 20 years in this field. Since lymphoma can affect anyone – males, females, young patients, older patients and all ethnicities – I am rewarded by the interaction with a variety of patients. Finally, lymphoma is a complex set of diseases that can affect any organ system and I was drawn to that challenge.

My practice team includes Lynn Rich, NP and Melinda Trotto, RN.

Conditions I Treat

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Waldenstrom macroglobulinemia
- Chronic lymphocytic leukemia

Professional Background

Jonathan W. Friedberg, M.D., is Director of the James P. Wilmot Cancer Institute, and Director of Hematological Malignancies Clinical Research.

He is a driving force behind the operations of our clinical and research programs.

Friedberg is a chair of the lymphoma committee in the SWOG group of the NCI National Clinical Trials Network, and is an independently R01-funded investigator in the field of lymphoid malignancies.

Dr. Friedberg received his medical degree from Harvard Medical School. His postgraduate training included an internship and residency at Massachusetts General Hospital. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in Boston. Dr. Friedberg also has an M.M.Sc. degree from Harvard Medical School in clinical investigation. He holds subspecialty certification in Medical Oncology and Hematology.

His research interests focus on development of novel therapies for patients with lymphoma. He formerly received a Scholar in Clinical Research award from the Leukemia & Lymphoma Society, based upon his work with an oral inhibitor of a protein called Syk, which demonstrated efficacy in the treatment of several different forms of lymphoma. He is currently funded as PI of the ILyAD trial, evaluating patients with follicular lymphoma receiving rituximab with a vitamin D intervention. As chair of SWOG, he is co-leader of the current North American intergroup effort in advanced stage Hodgkin lymphoma. He is also a founding member of the Lymphoma Epidemiology of Outcomes Consortium..

Credentials

Specialties

  • Hematology - American Board of Internal Medicine
  • Internal Medicine
  • Medical Oncology

Education

1990
BA | Williams College
Biology

1994
MD | Harvard Medical School
Medicine

2001
MS | Harvard Medical School
Clinical Investigation

Post-doctoral Training & Residency

07/01/1997 - 06/01/1999
Fellowship in Hematology/Oncology at Dana-Farber Cancer Institute

07/01/1995 - 06/01/1997
Residency in Internal Medicine at Massachusetts General Hospital

07/01/1994 - 06/30/1995
Internship in Internal Medicine at Massachusetts General Hospital

VIEW ALL expand_more

Awards

2012
Faculty Academic Mentoring Award
Sponsor: University of Rochester School of Medicine and Dentistry
Location: University of Rochester

2008 - 2008
Scholar in Clinical Research
Sponsor: Leukemia and Lymphoma Society

2008 - 2008
America's Top Doctors Selection

2007 - 2007
Jacob Gitelman Award
Sponsor: Gilda's Club and Cancer Action
Location: Rochester, NY

2004 - 2006
Lawrence A. Kohn Senior Teaching Fellow
Sponsor: Institute of Medicine
Location: Outstanding Teaching Contributions, Department of Medicine, Univ

2003 - 2003
Clinical Investigator Career Development Award
Sponsor: Lymphoma Research Foundation

2001 - 2003
Clinical Oncology Research Fellowship " Immunotherapy of Hodgkin's Disease"
Sponsor: Berlex Oncology Foundation

2001 - 2003
Rising stars program for innovative research
Sponsor: Dunkin Donuts and Dana-Farber Cancer Institute Department of Adu

VIEW ALL expand_more

Publications

Journal Articles

10/22/2019
Kamdar M, Li H, Chen RW, Rimsza LM, Leblanc ML, Fenske TS, Shea TC, Barr PM, Phillips TJ, Leonard JP, Kahl BS, Friedberg JW, Smith SM. "Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma." Blood advances.. 2019 Oct 22; 3(20):3132-3135.

10/2019
Zackon AYL, Ayers AA, Yeager KA, Somma ML, Friedberg JW, Flowers CR, Nastoupil LJ. "Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs." Leukemia & lymphoma.. 2019 Oct 0; 60(10):2356-2364. Epub 2019 Jun 04.

7/22/2019
Stephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, Leblanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi E, Leonard JP, Kahl B, Smith SM, Friedberg JW. "." Blood.. 2019 Jul 22; Epub 2019 Jul 22.

Books & Chapters

2008
Chapter Title: Lymphocyte-predominant Hodgkin's lymphoma. Evidence-based Hematology
Book Title: Evidence-based Hematology
Author List: McMahon B, Friedberg JW
Published By: Evidence based Hematology 2008

2008
Chapter Title: Monoclonal antibodies in lymphoma: the first decade.
Book Title: Seminars in Hematology
Author List: Link BK and Friedberg JW
Published By: Seminars in Hematology 2008

2008
Chapter Title: Non-myeloablative radioimmunotherapy for lymphoma.
Book Title: Seminars in Hematology
Author List: Schaefer-Cutillo J., Friedberg JW
Published By: Seminars in Hematology 2008

VIEW ALL PUBLICATIONS